Assignee

Regulus Therapeutics Inc.

Patents = 61

Trademarks = 4

Forward Citations = 606

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

50 inventors (with patents filed for the assignee):

Regulus Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing innovative medicines targeting microRNAs to treat a range of diseases. The company utilizes its proprietary oligonucleotide technologies to modify the activity of microRNAs, which are key regulators of gene expression.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com